1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Analysis & Statistics

Diagnostics Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • La Merie Publishing

All regions

1-8 of 8 reports

Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

  • $ 900
  • June 2019
  • 121 pages

Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about  Bispecific Antibodies for Immuno-Oncology & Other Diseases evaluates ...

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Immunotherapy
  • Targeted Delivery
  • Targeted Therapy

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

  • $ 2700
  • June 2019
  • 463 pages

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis This report provides you with a landscape description and analysis of T-cell and natural ...

  • Diagnostics
  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • United States

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

  • $ 2622
  • January 2018
  • 252 pages

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends It is estimated that ...

  • Diagnostics
  • Immunotherapy
  • Australia
  • United States
  • Immunocore Limited

mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals

  • $ 2565
  • June 2017
  • 260 pages

mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals For a long time, messenger RNA (mRNA) was thought to be a poor choice for a therapeutic ...

  • Diagnostics
  • Medical Biotechnology
  • Therapy
  • Australia
  • Moderna Therapeutics, Inc.

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies – 2016 Update

  • $ 1482
  • May 2016
  • 462 pages

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies – 2016 Update This Competitive Intelligence report about Biosimilar & Biosuperior Therapeutic Antibodies updates the competitive ...

  • Diagnostics
  • Genentech, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Roche Group

Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2016 Update

  • $ 456
  • February 2016
  • 46 pages

Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2016 UpdateThe Competitive Intelligence Report „Anti-VEGF/R Biosimilars and Biosuperiors ...

  • Biosimilar
  • United States
  • Eli Lilly & Co.
  • ImClone Systems Incorporated
  • Ophthotech Corporation

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

  • $ 2679
  • November 2015
  • 470 pages

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis This report describes and analyzes the situation of antibody-drug conjugates ...

  • Chemotherapy
  • Diagnostics
  • Therapy
  • United States
  • Seattle Genetics, Inc.

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

  • $ 1482
  • April 2015
  • 414 pages

Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competito ...

  • Diagnostics
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on